VNDA
Vanda Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.43
+1.69%Margins
Gross margin
92.8%
EBITDA margin
-77.2%
EBIT margin
-86.1%
Net margin
-127.4%
FCF margin
-89.7%
-124.8%
Return on equity
-66.6%
Return on assets
-76.4%
Return on invested capital
0.51x
Asset turnover
-$192.5M
Cash from operations
$2.81
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026